HomeBUSINESS
BUSINESS

Canalia, Japan’s 1st DPP-4/SGLT-2 Combo, Now Available
(Sep.8.2017)

Canalia
Canalia (teneligliptin + canagliflozin), Japan’s first fixed-dose combination drug of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, went on sale on September 7, Mitsubishi Tanabe Pharma and Daiichi Sankyo said ...
(LOG IN FOR FULL STORY)

News Calendar